Engaging and creating “Influencers” within an academic-industry environment
Lead Research Organisation:
University of Birmingham
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills. The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers’ understanding of each other’s needs and capabilities. This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ‘entrepreneurs in residence’ schemes. Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.
Organisations
People |
ORCID iD |
Publications
Bayley R
(2018)
MYBL2 Supports DNA Double Strand Break Repair in Hematopoietic Stem Cells.
in Cancer research
Gawley M
(2020)
Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme.
in Journal of controlled release : official journal of the Controlled Release Society
Chauhan A
(2020)
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure.
in Nature communications
Nikoi N
(2021)
Stability of Cell-Penetrating Peptide anti-VEGF Formulations for the Treatment of Age-Related Macular Degeneration
in Current Eye Research
Ahmed Z
(2022)
The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury.
in Clinical and translational medicine
Ahmed Z
(2022)
Inhibiting the DNA damage response pathway promotes functional recovery after spinal cord injury
in Clinical and Translational Discovery
| Description | Dropping the needle: Injection-free drug delivery to the eye |
| Amount | £229,008 (GBP) |
| Funding ID | RPGF1910\218 |
| Organisation | The Dunhill Medical Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 02/2023 |
| Description | MRC Confidence in Concept |
| Amount | £56,213 (GBP) |
| Funding ID | CiC 4 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2016 |
| End | 08/2019 |
| Description | MRC Confidence in Concept |
| Amount | £97,433 (GBP) |
| Funding ID | CiC 6.1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2019 |
| End | 04/2021 |
| Description | Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics |
| Amount | £1,185,446 (GBP) |
| Funding ID | 104777 |
| Organisation | Innovate UK |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2018 |
| End | 03/2021 |
| Description | Royal Academy of Engineering Fellowship |
| Amount | £60,000 (GBP) |
| Funding ID | EF1617/6/5 |
| Organisation | Royal Academy of Engineering |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2017 |
| End | 02/2018 |
| Description | Topical delivery of Mitia drug using Cell Penetrating Peptide |
| Amount | £509,997 (GBP) |
| Organisation | Macregen |
| Sector | Private |
| Country | United States |
| Start | 03/2018 |
| End | 09/2019 |